ESG is an incision-less endoscopic procedure that leaves no scars and requires no pills or injections. It’s designed to help you eat less and feel full faster, which can help you achieve significant, lasting weight loss.1
1. For the Apollo ESG™ System, you need to follow a healthy diet and exercise program to lose weight. You may not lose weight if you do not adopt healthy habits. Your doctor’s clinical team, including dietitians, nutritionists, and/or exercise trainers, should help you on your weight-loss journey.
This patient testimonial is sponsored by Boston Scientific.
Results in other cases may vary. In a study, patients with class 1 (BMI 30 to <35 kg/m²) or class 2 (BMI 35 to <40 kg/m²) obesity who underwent ESG in conjunction with prescribed diet and exercise counseling achieved an average of 13.6% total body weight loss at year one.
ESG reduces the size of your stomach without incisions or scars. This small suturing device attaches to a camera passed through your mouth into your stomach while you are asleep. A specially trained doctor sews your stomach into a smaller shape, so you eat less and feel full faster.1,2
1. For the Apollo ESG™ System, you need to follow a healthy diet and exercise program to lose weight. You may not lose weight if you do not adopt healthy habits. Your doctor’s clinical team, including dietitians, nutritionists, and/or exercise trainers, should help you on your weight-loss journey.
2. Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): A prospective, multicentre, randomised trial. Lancet. 2022;400:441–451.
This patient testimonial is sponsored by Boston Scientific.
Results in other cases may vary. In a study, patients with class 1 (BMI 30 to <35 kg/m²) or class 2 (BMI 35 to <40 kg/m²) obesity who underwent ESG in conjunction with prescribed diet and exercise counseling achieved an average of 13.6% total body weight loss at year one.
This patient testimonial is sponsored by Boston Scientific.
Results in other cases may vary. In a study, patients with class 1 (BMI 30 to <35 kg/m²) or class 2 (BMI 35 to <40 kg/m²) obesity who underwent ESG in conjunction with prescribed diet and exercise counseling achieved an average of 13.6% total body weight loss at year one.
It’s an endoscopic procedure that has no scars or incisions. The provider puts an endoscope down the mouth of the patient into the stomach to perform the procedure. The patient is under anesthesia the whole time.
Unlike a traditional surgical sleeve procedure, ESG is performed without any incisions, and no part of the stomach is removed. It’s similar because it limits the amount of food a person can eat by reducing the size of the stomach.
People usually go home the same day and generally can return to routine daily activity in 2–3 days.1 Follow your doctor’s specific instructions.
ESG can be part of achieving weight loss, but it requires a lasting commitment to losing weight. To keep weight off, it’s important to live a healthy lifestyle, including eating well and staying active.
Each person has different results. In a clinical study, patients lost an average of 13.6% of their total body weight 12 months after undergoing the ESG procedure and following a prescribed diet and exercise program.1
The most common side effects are gastrointestinal symptoms such as nausea, abdominal pain, vomiting, constipation, burping or diarrhea. These symptoms typically resolve within 30–60 days.
All procedures have risk. Talk with your doctor and be sure you understand all the risks before you have any procedure.
ESG is for adults with obesity and a body mass index (BMI) of 30–50 kg/m2 who have not been able to lose weight or maintain weight loss through diet and exercise alone. Talk to a doctor about whether you’re a good candidate.
People who are unable to have an upper endoscopy, are pregnant, are using certain types of blood-thinning medications, or have malignant tissue, large hiatal hernia, potentially bleeding gastric lesions, or eating disorders are not eligible for the procedure.
Your provider can work with you one-on-one on to discuss coverage or financing options for your procedure.
1. Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): A prospective, multicentre, randomised trial. Lancet. 2022;400:441–451.
*Individual weight loss may vary.
Results in other cases may vary. In a study, patients with class 1 (BMI 30 to <35 kg/m²) or class 2 (BMI 35 to <40 kg/m²) obesity who underwent ESG in conjunction with prescribed diet and exercise counseling achieved an average of 13.6% total body weight loss at year one.
1. For the Apollo ESG™ System, you need to follow a healthy diet and exercise program to lose weight. You may not lose weight if you do not adopt healthy habits. Your doctor’s clinical team, including dietitians, nutritionists, and/or exercise trainers, should help you on your weight-loss journey.
2. Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): A prospective, multicentre, randomised trial. Lancet. 2022;400:441–451.
Apollo ESG™ Safety Information for Patients
Apollo ESG™ devices are made to help you lose weight by reducing the size of your stomach and increasing the time it takes for food to pass through your stomach.
For Apollo ESG™, you need to follow a healthy diet and exercise program to lose weight. You may not lose weight if you do not adopt healthy habits. Your doctor’s clinical team, including dietitians, nutritionists, and/or exercise trainers, should help you on your weight-loss journey.
Apollo ESG™ System is for adults with obesity (BMI 30–50kg/m2) who have not been able to lose weight and keep it off through more conservative measures (e.g., diet and exercise).
Your doctor will ask you about your medical history and will also perform a physical examination to determine your eligibility for the Apollo ESG™ device. Additionally, at the time of your procedure, the doctor may identify internal factors, such as stomach ulcers or erosive gastritis, which may prevent you from receiving the device.
You must not receive Apollo ESG™ if you are pregnant. You must not receive Apollo ESG™ if you have an eating disorder (anorexia nervosa, binge eating disorder, etc.). All procedures have risk. Patients should talk to their doctor and understand all risks before having a procedure.
Nausea and vomiting, abdominal pain, constipation, eructation, heartburn and diarrhea are common after the ESG. Gastrointestinal bleeding may also be experienced following these procedures. More serious complications have been reported, though these are relatively rare.
While many patients are discharged from the hospital on the day of their procedure, some patients may stay in the hospital or return to the hospital for assistance with symptoms associated with acclimating to the sleeve. Symptoms are most often treated with IV fluids or medication, but medical intervention may be required.
Call your doctor if you have any concerns about your health or well-being following an ESG.
Some patients may not lose weight following a procedure with Apollo ESG™. Others may lose weight and then report that they no longer feel full after a meal, like they did when they first had their procedure. In such cases, the sleeve may have been compromised. Talk to your doctor about your options. You may be a candidate to have the sleeve restored or to have another type of weight-loss procedure.
If you have additional questions, talk with your doctor. For full safety information, visit IFU-BSCI.com.
CAUTION Rx only
